Skip to main content
. 2013 Oct;37(4):379–388. doi: 10.5142/jgr.2013.37.379

Fig. 3. Schematic description for the progression of diabetic nephropathy in the type 1 and 2 diabetes animal models. STZ, streptozotocin; i.p., intraperitoneal; OLETF, Otsuka Long-Evans Tokushima Fatty.

Fig. 3.